![]() |
Volumn 310, Issue 2-3, 2001, Pages 113-116
|
Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice
|
Author keywords
Cytokines; Hyperalgesia; Interleukin 1 receptor; Neuropathy; Tumor necrosis factor alpha
|
Indexed keywords
INTERLEUKIN 1 RECEPTOR;
INTERLEUKIN 1 RECEPTOR ANTIBODY;
INTERLEUKIN 1BETA;
NEUTRALIZING ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
UNCLASSIFIED DRUG;
ALLODYNIA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DRUG EFFICACY;
FEMALE;
HYPERALGESIA;
MONOTHERAPY;
MOUSE;
NERVE INJURY;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SCIATIC NERVE;
ANIMALS;
ANTIBODIES;
FEMALE;
HYPERALGESIA;
IMMUNOTHERAPY;
MICE;
MICE, INBRED C57BL;
NEURALGIA;
PERIPHERAL NERVES;
RECEPTORS, INTERLEUKIN-1;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0035860482
PISSN: 03043940
EISSN: None
Source Type: Journal
DOI: 10.1016/S0304-3940(01)02077-8 Document Type: Article |
Times cited : (100)
|
References (18)
|